专利检索 ap:("FIBROGEN, INC.") AND inv:"Flyvbjerg, Allan" 第 1 页

1.

发明公开
CTGF as target for the therapy of diabetic nephropathy 审中-公开
标题翻译：糖尿病患者的CTGF抑制剂zur Behandlung von Proteinurie

公开(公告)号：EP1977762A1

公开(公告)日：2008-10-08

申请号：EP08011905.0

申请日：2005-02-11

申请人： FIBROGEN, INC.

发明人： Flyvbjerg, Allan , Guo, Guangjie , Liu, David Y. , Neff, Thomas B. , Oliver, Noelynn A. , Usinger, William R. , Wang, Qingjian

IPC分类号： A61K39/39 , A61K39/395 , A61K31/00 , A61K38/00 , A61P13/12

CPC分类号： A61K38/556 , A61K31/00 , A61K39/395 , A61K2039/505 , C07K16/22 , A61K2300/00

摘要： The present invention relates to methods and compounds for treating specific early stage aspects and late stage aspects of diabetic nephropathy. Methods and compounds for treating various physiological features associated with early stage and with late stage diabetic nephropathy are also provided.

摘要翻译： 本发明涉及用于治疗糖尿病肾病的特异性早期方面和晚期方面的方法和化合物。还提供了用于治疗与早期和晚期糖尿病肾病相关的各种生理特征的方法和化合物。